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Autoimmune diseases are chronic conditions initiated by 
the loss of immunological tolerance to self-antigens and 
represent a heterogeneous group of disorders that aﬄ   ict 
speciﬁ   c target organs or multiple organ systems. Th  e 
chronic nature of these diseases places a signiﬁ  cant 
burden on the utilization of medical care, direct and 
indirect economic costs, and quality of life. Almost all 
autoimmune diseases disproportionately aﬀ  ect middle-
aged women and are among the leading causes of death 
for this group of patients. With increasing age of patients, 
the female-to-male ratio for autoimmune diseases becomes 
more prominent.
Th  e autoimmune tautology refers to the fact that 
autoimmune diseases share several clinical signs and 
symptoms, physiopathologic mechanisms, and genetic 
factors and this fact indicates that they have a common 
origin (Table  1). In the previous issue of Arthritis 
Research & Th  erapy, Eyre and colleagues [1] report that 
variation within the TAGAP gene, at 6q25.3, is associated 
with three autoimmune diseases, namely rheumatoid 
arthritis, type 1 diabetes, and coeliac disease, in 
Caucasians. In addition, the authors conﬁ  rmed other loci 
associated with these diseases in their population: 
CTLA-4, the IL2-21  region, 6q23 (TNFAIP3),  SH2B3, 
PRKCQ, and MMEL1 [1].
Th  e impact of genetic predisposition on susceptibility 
to autoimmune diseases was ﬁ  rst  identiﬁ   ed by the 
analysis of disease concordance rates in monozygotic 
twins (concordance rates ranged from about 15% to 57%) 
[2]. Th  e decrease in the concordance rates of siblings 
compared with the rate among monozygotic twins 
supports the presence of multiple genes contributing to 
the autoimmune phenotype onset.
A primary characteristic of complex diseases is that 
aﬀ  ected individuals tend to cluster in families (that is, 
familial aggregation, also referred to as recurrence risk). 
Recurrent associations of autoimmune diseases in family 
members of patients have been reported. Although non-
genetic factors may have an eﬀ  ect on familial aggregation, 
shared genetic factors, in fact, may be the most likely 
cause for this aggregation [3]. However, segregation of 
autoimmunity is fairly well understood.
Becker and colleagues [4], on the basis of previous 
autoimmune disease linkage studies, reported 18 common 
non-major histocompatibility complex loci clusters and 
hypothesized a shared genetic basis for the autoimmune 
trait. Since then, several reports, including that of Eyre 
and colleagues, have conﬁ  rmed that autoimmune pheno-
types might represent pleiotropic outcomes of non-
speciﬁ  c disease genes [1,5-8]. However, the ﬁ  nding of a 
polymorphism associated with a trait is not complete 
until the functional relevance is examined and its 
biological eﬀ  ect on such a trait is understood.
It is noteworthy that not all autoimmune diseases share 
the same genetic susceptibility. Th  us, the genetic risk 
factors for autoimmune diseases might well consist of 
two forms: those common to many autoimmune diseases 
and those speciﬁ  c to a given disorder. Combinations of 
common and disease-speciﬁ  c alleles at HLA and non-
HLA genes, in interaction with epigenetic and environ-
mental factors over time (that is, gluten, tobacco, 
Abstract
    Although autoimmune diseases exhibit contrasting 
epidemiological features, pathology, and clinical 
manifestations, three lines of evidence demonstrate 
that these diseases share similar immunogenetic 
mechanisms (that is, autoimmune tautology). First, 
clinical evidence highlights the co-occurrence of 
distinct autoimmune diseases within an individual 
(that is, polyautoimmunity) and within members 
of a nuclear family (that is, familial autoimmunity). 
Second, physiopathologic evidence indicates that 
the pathologic mechanisms may be similar among 
autoimmune diseases. Lastly, genetic evidence shows 
that autoimmune phenotypes might represent 
pleiotropic outcomes of the interaction of non-specifi  c 
disease genes.
© 2010 BioMed Central Ltd
The autoimmune tautology
Juan-Manuel Anaya*
See related research by Eyre et al., http://arthritis-research.com/content/12/5/R175
EDITORIAL
*Correspondence: anayajm@gmail.com
Center for Autoimmune Diseases Research (CREA), School of Medicine and Health 
Sciences, Universidad del Rosario, Carrera 24 # 63C-69, 111221, Bogota, Colombia
Anaya Arthritis Research & Therapy 2010, 12:147 
http://arthritis-research.com/content/12/6/147
© 2010 BioMed Central LtdEpstein-Barr virus, cytomegalovirus, and so on), will 
determine the ﬁ  nal clinical autoimmune phenotype [9]. 
Yet only around 10% to 15% of the inherited risk for 
autoimmune diseases can be explained at present [7,8]. 
Most of the common variants individually or in 
combination confer relatively small increments in risk 
(1.1- to 1.5-fold) and explain only a small proportion of 
heritability (that is, the proportion of phenotypic 
variation in a population that is attributable to genetic 
variation among individuals). Th   e amount of heritability 
depends on the investigated population because 
variations in both additive and non-additive genetic 
factors and the environmental variance are speciﬁ  c to the 
population [10]. As a corollary, genetic results should be 
conﬁ  rmed in diﬀ  erent populations [11]. Th   ere are several 
examples in which polymorphisms inﬂ  uencing the risk 
for developing autoimmune diseases in a particular 
population are not replicated in another one. Besides the 
inner characteristic of the studied popu  lation and 
gradients of allelic frequencies among popula  tions, other 
explanations for the missing heritability have been 
suggested: much larger numbers of variants of smaller 
eﬀ  ect yet to be found; rarer variants (possibly with larger 
eﬀ  ects) that are poorly detected by available genotyping 
arrays that focus on variants present in 5% or more of the 
population; structural variants poorly captured by 
existing arrays; low power to detect gene-gene 
interactions; and failure to account adequately for a 
shared environment among relatives [12]. Potential 
sources of missing heritability and research strategies to 
elucidate the genetics of complex diseases have been 
proposed [12]. It is evident, however, that the rapid 
development of DNA sequencing technologies and the 
continuously improving depth of coverage of poly-
morphisms by DNA chips for genome-wide association 
studies will contribute to an extremely expansive phase of 
genetic research.
Identiﬁ  cation of genetic causes of autoimmune diseases 
will enhance our understanding of the mechanisms 
common to multiple autoimmune diseases and to speciﬁ  c 
ones and will assist in providing increasing predictive 
capacity to identify subjects at risk for these devastating 
diseases and to identify new therapeutic interventions. 
Th  us, in the near future, we should be able to predict 
which families or individuals within families may have a 
higher predisposition to develop an autoimmune 
phenotype by inspecting his or her family medical 
history, ancestry, and genetic and autoantibody proﬁ  le 
[3].  Although much progress has been made in 
identifying genetic factors that inﬂ  uence susceptibility to 
auto  immune diseases, progress is lacking in identifying 
those factors that inﬂ   uence disease progression or 
complica  tions. It is conceivable that only a subset of the 
genetic factors that inﬂ  uence susceptibility to disease also 
inﬂ  u  ence disease progression and complications.
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